Napoleon Moulavasilis

National and Kapodistrian University of Athens

Papers

1

Total Citations

15

H-Index

1

About

Dr. Napoleon Moulavasilis is a leading urologic oncologist whose research focuses on the comparative effectiveness of minimally invasive treatments for renal cell carcinoma. His most-cited work, a 2024 propensity-matched cohort study, provides critical long-term follow-up data comparing percutaneous microwave ablation to robot-assisted partial nephrectomy for Stage I kidney cancer. This study, already garnering 15 citations, directly informs clinical decision-making by evaluating oncologic outcomes between these two nephron-sparing approaches. Dr. Moulavasilis’s contributions lie in bridging the gap between interventional radiology and surgical oncology, offering evidence that helps tailor treatment to patient-specific factors. His research is particularly impactful for urologists and oncologists seeking to optimize outcomes while minimizing morbidity. By focusing on long-term follow-up, he addresses a key gap in the literature, ensuring that comparative effectiveness studies reflect real-world durability. Dr. Moulavasilis’s work continues to shape guidelines and practice patterns in the management of early-stage kidney cancer, making him a valuable voice in the evolving landscape of renal cell carcinoma treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
15
Total Citations
15
Avg Citations/Paper
🏆 Most Cited Paper
Percutaneous Microwave Ablation Versus Robot-Assisted Partial Nephrectomy for Stage I Renal Cell Carcinoma: A Propensity-Matched Cohort Study Focusing Upon Long-Term Follow-Up of Oncologic Outcomes
15 citations · 2024
📈 Most Prolific Year: 2024 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: National and Kapodistrian University of Athens

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago